This study investigates pancreatic ductal adenocarcinoma. Participants will undergo imaging to help detect metastatic disease.
The study focuses on evaluating how well the imaging test works in identifying the spread of the disease. It looks at the accuracy of the test in finding cancer that has spread.
- Who can participate: Adults aged 18 and older with confirmed pancreatic ductal adenocarcinoma may join. Eligibility requires a specific performance status and informed consent.
- Study details: Participants will receive an investigational imaging test.
- Study timelines: The study will last approximately 24 months.